Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
UNIVERSITY OF HAWAII currently has 1 pending office action. This matter is assigned to a sole distinct examiner, VANHORN, ABIGAIL LOUISE. As the busiest examiner for the portfolio, this individual is responsible for 1 pending office action. The data shows 0 distinct art units associated with this pending activity.
The reliance on a single examiner means that the current prosecution outcome depends on one individual's interpretation. Practitioners should focus on the specific patterns of VANHORN, ABIGAIL LOUISE to navigate this pending action. The absence of multiple art units suggests a very narrow or specialized focus for the current pending matter. This concentrated workload allows for a direct and singular prosecution strategy for the pending office action.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORGAN, BAILEY MICHELLE | 1 | 56.3% | +58.3% |
| GILL, RACHEL B | 1 | 65.6% | +28.3% |
| CHENG, KAREN | 1 | 76.3% | +26.7% |
| TON, TRI T | 1 | 86.1% | +10.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | GILL, RACHEL B | 125d overdue |
| 17720687 | METHODS OF PARTICLE MANIPULATION AND ANALYSIS | TON, TRI T | 70d overdue |
| 18268032 | BURKHOLDERIA VACCINES AND THERAPEUTICS | MORGAN, BAILEY MICHELLE | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | GILL, RACHEL B | 125d overdue |
| 17720687 | METHODS OF PARTICLE MANIPULATION AND ANALYSIS | TON, TRI T | 70d overdue |
| 17774723 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | CHENG, KAREN | 43d overdue |
| 18268032 | BURKHOLDERIA VACCINES AND THERAPEUTICS | MORGAN, BAILEY MICHELLE | 14d |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1671 | 1 |
| 1623 | 1 |
| 2877 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18268032 | BURKHOLDERIA VACCINES AND THERAPEUTICS | MORGAN, BAILEY MICHELLE | 1645 | §101§102 | Final Rejection | 14d | Pending | Jun 16, 2023 |
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | GILL, RACHEL B | 1671 | §102§103§112 | Non-Final OA | 125d overdue | Pending | Jan 24, 2023 |
| 17774723 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | CHENG, KAREN | 1623 | §103 | Non-Final OA | 43d overdue | Pending | May 05, 2022 |
| 17720687 | METHODS OF PARTICLE MANIPULATION AND ANALYSIS | TON, TRI T | 2877 | §103§112 | Non-Final OA | 70d overdue | Pending | Apr 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial